Health : Diseases, Disorders, and Disciplines

Project A.L.S.

Finding and funding treatments and a cure for ALS

Rating

Overall Rating    
      (45.79)
Organizational Efficiency      
Program Expenses 89.7%    
Administrative Expenses 4.7%    
Fundraising Expenses 5.4%    
Fundraising Efficiency $0.04    
Efficiency Rating    
      (38.97)
Organizational Capacity      
Primary Revenue Growth 2.1%    
Program Expenses Growth 0.9%    
Working Capital Ratio (years) -0.05    
Capacity Rating    
      (6.81)

Income Statement     (FYE 07/2007)

Revenue  
Primary Revenue $3,426,796
Other Revenue $-50,598
Total Revenue $3,376,198
   
Expenses  
Program Expenses $2,742,708
Administrative Expenses $146,457
Fundraising Expenses $165,562
Total Functional Expenses $3,054,727
   
Payments to Affiliates $0
Excess (or Deficit) for the year $321,471
   
Net Assets $170,048

Charts

Expenses Breakdown

Expenses Legend

Revenue/Expenses Trend

Revenue-Expense Legend

Contact Information

Project A.L.S.
900 Broadway
Suite 901
New York, NY 10003
tel: (800) 603-0270
fax: (212) 420-7387
EIN: 13-4019464

Contact Email
Visit Web Site

Leadership      (FYE 07/2007)

Name Title Compensation % of Expenses
Meredith Estess President (The person identified as holding the highest position of management, and therefore who would normally be responsible for carrying out the mission of the charity and leading the organization on a day-to-day basis.) $126,042 4.12%
Other Salaries of Note
Valerie Estess Director of Research (Using information reported on an organization's most recent Form 990, we include as compensation an individual's salary, cash bonuses, and expense accounts and other allowances. We do not include contributions to benefit plans or compensation deferred to a future date.) $132,211 4.32%

Donor Privacy Policy

YES, this charity has a written donor privacy policy.

Mission

Jenifer Estess, her family, and friends, started Project A.L.S. in 1998, when Jenifer was diagnosed with the fatal brain disease. Upon discovering that there were no effective treatments, Project A.L.S. set out to put medicine into place. The mission today is to bring the best science to ALS patients in the form of effective treatments and, ultimately, a cure. Project A.L.S. has raised over $37 million, directing 81% to research programs. The majority of fundraising proceeds goes to support investigations in genetics, drug discovery, stem cells, and disease pathways. The hallmark of Project A.L.S. research is collaboration. Researchers who were competitors now play on the same team, meet regularly, share data openly, and work rationally, constructively, and aggressively toward shared goals.

Charities Performing Similar Types of Work

 
 

Kiplinger's 2007TIMEPC MagazineForbesCrystalTech